ROS interact with mitochondrial ROS to promote ECM accumulation and the fibrogenic response through modulation of endothelial nitric oxide synthase dysfunction in mesangial cells. In addition, after TGF-␤ 1 induction, generated ROS have been reported to promote cardiac myofibroblast activation and differentiation (3) . However, the role of ROS in TGF-␤ 1 signaling and the cross-talk between these two profibrogenic signals during kidney myofibroblast activation are still not very well defined. One of the major facets that are highlighted by Manickam et al. in their study (13) relates to the involvement of NADPH oxidase-derived ROS and a third set of molecules, i.e., the Rho family of small GTPases, in the TGF-␤ 1 signaling pathway; these molecules form an intricate signaling complex that exerts a stimulating effect on myofibroblast activation. In an earlier work by these authors, they demonstrated in vitro that TGF-␤ 1 -induced renal myofibroblast activation is regulated through NADPH oxidases of the Nox family, whereby this profibrogenic cytokine stimulates an increase in Nox4 expression and generation of NADPH oxidase-derived ROS. The downstream effect of Nox4 included the acquisition of myofibroblast markers, e.g., ␣-smooth muscle actin and increased synthesis of fibronectin (2). Thus, Nox4-derived ROS were considered as second messengers in the TGF-␤ 1 signaling pathway, where, in a hierarchical order, they are placed downstream of Smad3 but upstream of ERK1/2 during the transformation of fibroblasts to myofibroblasts (2) . Furthermore, another interesting aspect of their study relates to the inclusion of another unique molecule, i.e., Nox4 enhancer protein, polymerase (DNA-directed) ␦-interacting protein 2 (Poldip2), in the TGF-␤ 1 -induced signaling pathway. It seems that during redox signaling with myofibroblast activation of kidney fibroblasts, Poldip2 serves as an upstream regulatory factor, whereby it interacts with Nox4 and enhances NADPH oxidase activity, and, in turn, Nox4 reciprocally upregulates the expression of this interacting protein: a unique reciprocal cooperative relationship between these two putative second messengers (13) .
Based on previous work, Barnes and colleagues further explored and confirmed the regulatory roles of the Rho family of small GTPases, RhoA and its downstream effector Rho kinase (ROCK), during renal myofibroblast activation as well as their interrelationship with Poldip2/Nox4 and NADPH oxidase-generated ROS in the TGF-␤ 1 -induced signaling pathway (13) . Rho GTPases are a family of small GTP-binding proteins that belong to the Ras superfamily. They cycle between an active GTP-bound and inactive GDP-bound form to act as "molecular switches" that regulate complex cellular processes and signaling pathways (4) . Three key members of the family (Rac1, RhoA, and Cdc42) have been widely studied in the regulation of cytoskeleton and actin dynamics. While both Rac1 and RhoA have been reported to be involved in ECM pathobiology and fibrogenesis, Rac1 is activated in response to TGF-␤ 1 and promotes mesangial cell collagen accumulation through phosphatidylinositol 3-kinase/Akt pathways (6) . RhoA kinase-ROCK inhibition has been widely confirmed to be beneficial in the amelioration of diabetic nephropathy and renal fibrosis, partly by preventing ECM accumulation and antioxidative effects (8, 14) . Recent accumulated evidence has also highlighted the convergent role of Rho signaling in response to profibrogenic mediators such as TGF-␤ 1 , endothelin-1, and integrins that result in myofibroblast activation (14, 16) .
Using targeted gene knockdown techniques and chemical inhibitors in rat kidney fibroblast cells, the authors demonstrated that TGF-␤ 1 rapidly induces the activation of both RhoA GTPase and ROCK but not Rac1, another member of the Rho family. Rho/ROCK can modulate the expression of Nox4 and the Nox4 enhancer protein Poldip2, but the latter two have no effect on RhoA, indicating that Nox4 is "downstream" of Rho/ROCK (13) . In this regard, the importance of Rho/ROCK regulation on TGF-␤ 1 -induced NADPH oxidase-derived ROS signaling during myofibroblast activation has been clearly verified by Barnes and colleagues, at least in cell types such as kidney fibroblasts. Intriguingly, in vascular smooth muscle cells, RhoA has been reported to be "downstream" of Poldip2/ Nox4 in response to TGF-␤ 1 induction (12) . The authors explained these peculiar differences, i.e., "reverse order of signaling" as due to possible heterogeneity in cellular signaling in different cell types, and it is also conceivable that Rho/ ROCK-induced Poldip2 and Nox4-dependent ROS may reciprocally modulate each other to amplify the TGF-␤ 1 signaling cascade, resulting in myofibroblast activation. Taken together, the authors' current and previous works collectively delineate a "unique hierarchy" in the RhoA/ROCK/Poldip2/Nox4/ERK signaling cascade that is initiated by TGF-␤ 1 in kidney myofibroblast differentiation in renal fibrosis (Fig. 1) .
The elucidation of this unique signaling cascade raises one or two important issues that need further investigation: 1) whether other cell types, such as pericytes, circulating bone marrow-derived fibrocytes, tubular epithelial cells, or endothe- Fig. 1 . Conceivable transforming growth factor (TGF)-␤1-initiated cellular events leading to myofibroblast activation and extracellular matrix (ECM) synthesis culminating into renal fibrosis. In the canonical pathway, phosphorylated Smad3 interacts with Smad4, and the complex translocates into the nucleus to initiate the transcription of the targeted genes. Smad3 can also modulate Nox4 to generate ROS, which can activate the MEK/ERK1/2 pathway. Finally, TGF-␤1 can modulate Rho/Rho kinase (ROCK) activities to increase the expression of Nox4, which is further enhanced by polymerase (DNAdirected) ␦-interacting protein 2 (Poldip2), and the interaction of NOX4:Polydip2 leads to the modulation of various cellular processes as well as excessive generation of ROS. The latter putative second messengers lead to activation of the ERK1/2 pathway, myofibroblast differentiation, and aberrant synthesis of ECM proteins. The existence of the latter transduction pathway (Rho/ROCK/Poldip2/Nox4/MEK/ERK1/2) is underscored in a study by Manickam et al. (13) . TGF-␤R, TGF-␤ receptor [types I-III (RI-RIII)]; GEF, guanine nucleotide exchange factor; ␣-SMA, ␣-smooth muscle actin; CTGF, connective tissue growth factor. lial cells (amenable to epithelial or endothelial-mesenchymal transitions), also undergo a transformation to acquire a myofibroblast phenotype similar to kidney fibroblasts following TGF-␤1-induced and RhoA and NADPH oxidase-dependent signaling pathway, and 2) whether mitochondrial-derived ROS, another major source of ROS, have any effect on TGF-␤ 1 -dependent renal fibrosis. Finally, further in vivo investigations on the specific roles of small GTPase and NADPH oxidase-derived ROS in TGF-␤ 1 -induced myofibroblast activation during renal fibrosis would be helpful to verify the possible therapeutic targets alluded to by the authors in their in vitro investigations.
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